Shares of Moderna are trading higher Tuesday morning, as Wall Street analysts upgrade their ratings following landmark Phase 3 oncology data.

Shares of Moderna are trading lower Monday morning, taking a breather following a multi-day surge driven by clinical trial success.

Shares of Moderna are trading higher Tuesday morning, as Wall Street analysts upgrade their ratings following landmark Phase 3 oncology data.

Moderna shares are trading lower Wednesday morning, pausing after a 150% surge on landmark clinical trial updates for its oncology pipeline.

Moderna announces a $2 billion convertible senior note offering to fund its oncology business growth and strategically manage debt.

Shares of Moderna are trading lower Friday morning after the company announced official terms for a major private debt offering.